Hosted on MSN7mon
Researchers from UGA develop nasal vaccine for COVID
A nasal vaccine for COVID 19 ... by He containing modified strains of parainfluenza virus 5, which causes kennel cough in dogs but is harmless to humans. CyanVac was founded by Biao He, Regents ...
Business Wire1mon
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
PIV5 has been commonly administered to dogs as part of combination distemper/kennel cough vaccines for decades. Blue Lake Biotechnology is developing BLB201 as an intranasal vaccine to prevent ...
Yahoo Finance1mon
First Subject Dosed in Initial Cohort of Phase 2b Clinical Study of CyanVac’s Intranasal COVID-19 Vaccine Candidate
December 09, 2024--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines ... part of combination distemper/kennel cough vaccines for decades.
KIMT11d
Rochester animal clinic shares warning signs of kennel cough as cases spike
Symptoms of kennel cough include a hacking cough, gagging, runny noses, sneezing, and nasal discharge. For pets that are vaccinated ... "keeping your pet updated on the vaccination, especially if ...